Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Mast cells contribute importantly to both protective and pathological IgE-dependent immune responses. We show that the mast cell–expressed orphan serpentine receptor mCCRL2 is not required for expression of IgE-mediated mast cell–dependent passive cutaneous anaphylaxis but can enhance the tissue swelling and leukocyte infiltrates associated with such reactions in mice. We further identify chemerin as a natural nonsignaling protein ligand for both human and mouse CCRL2. In contrast to other “silent” or professional chemokine interreceptors, chemerin binding does not trigger ligand internalization. Rather, CCRL2 is able to bind the chemoattractant and increase local concentrations of bioactive chemerin, thus providing a link between CCRL2 expression and inflammation via the cell-signaling chemerin receptor CMKLR1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bulanova, E., Budagian, V., Orinska, Z., Hein, M., Petersen, F., Thon, L., Adam, D., & Bulfone‐Paus, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3880 · Cited by 116
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mast cells in the development of adaptive immune responses
Galli, S. J., Nakae, S., & Tsai, M. (2005) · Nature Immunology · doi:10.1038/ni1158 · Cited by 1,279
Self-citationWittamer, V., Franssen, J.-D., Vulcano, M., Mirjolet, J.-F., Le Poul, E., Migeotte, I., Brézillon, S., Tyldesley, R., Blanpain, C., Detheux, M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030382 · Cited by 888
Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells
Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M., Hub, E., & Rot, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80422-5 · Cited by 729
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.
Liu, F., Bohn, J., Ferry, E. L., Yamamoto, H., Molinaro, C. A., Sherman, L. A., Klinman, N. R., & Katz, D. H. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.6.2728 · Cited by 631
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Mantovani, A., Bonecchi, R., & Locati, M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1964 · Cited by 481
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J. D., Tsai, M., & Galli, S. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2238 · Cited by 412
Self-citation
Cited by
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Chemerin: at the crossroads of inflammation and obesity
Ernst, M. C., & Sinal, C. J. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.08.001 · Cited by 425
Sell, H., Laurencikiene, J., Taube, A., Eckardt, K., Cramer, A., Horrighs, A., Arner, P., & Eckel, J. (2009) · Diabetes · doi:10.2337/db09-0277 · Cited by 387
The complex role of adipokines in obesity, inflammation, and autoimmunity
Taylor, E. B. (2021) · Clinical Science · doi:10.1042/cs20200895 · Cited by 330
Davenport, A. P., Alexander, S. P. H., Sharman, J. L., Pawson, A. J., Benson, H. E., Monaghan, A. E., Liew, W. C., Mpamhanga, C. P., Bonner, T. I., Neubig, R. R., et al. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007179 · Cited by 327
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Chemerin: a multifaceted adipokine involved in metabolic disorders
Helfer, G., & Wu, Q.-F. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0174 · Cited by 315
Lehrke, M., Becker, A., Greif, M., Stark, R., Laubender, R. P., von Ziegler, F., Lebherz, C., Tittus, J., Reiser, M., Becker, C., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0380 · Cited by 299
Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism
Bondue, B., Wittamer, V., & Parmentier, M. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.11.004 · Cited by 294
“CCRL2 was therefore suggested to increase the local concentration of chemerin and present the protein to other nearby cells displaying ChemR23 on their surface [32].”
BackgroundSex dimorphism and depot differences in adipose tissue function
White, U. A., & Tchoukalova, Y. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.006 · Cited by 284
Towards an integrative approach to understanding the role of chemerin in human health and disease
Rourke, J. L., Dranse, H. J., & Sinal, C. J. (2013) · Obesity Reviews · doi:10.1111/obr.12009 · Cited by 281
Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes
Ernst, M. C., Issa, M., Goralski, K. B., & Sinal, C. J. (2010) · Endocrinology · doi:10.1210/en.2009-1098 · Cited by 259
Chemerin regulates β-cell function in mice
Takahashi, M., Okimura, Y., Iguchi, G., Nishizawa, H., Yamamoto, M., Suda, K., Kitazawa, R., Fujimoto, W., Takahashi, K., Zolotaryov, F. N., et al. (2011) · Scientific Reports · doi:10.1038/srep00123 · Cited by 149
Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox
Neves, K. B., Nguyen Dinh Cat, A., Lopes, R. A. M., Rios, F. J., Anagnostopoulou, A., Lobato, N. S., de Oliveira, A. M., Tostes, R. C., Montezano, A. C., & Touyz, R. M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05616 · Cited by 113
“Binding to chemokine receptor-like 2 does not seem to activate signaling pathways and may act as an inhibitor of chemerin-induced cellular responses.(16) In mice fed high-fat diet, chemerin expression is upregulated in adipocytes,(17,18) and in db/db mice, a model of diabetes mellitus–associated obesity, levels of che…”
BackgroundKunimoto, H., Kazama, K., Takai, M., Oda, M., Okada, M., & Yamawaki, H. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00820.2014 · Cited by 79
Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration
Farsam, V., Basu, A., Gatzka, M., Treiber, N., Schneider, L. A., Mulaw, M. A., Lucas, T., Kochanek, S., Dummer, R., Levesque, M. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13446 · Cited by 59
“This notion is based on the finding that CCRL2 possesses an altered amino acid sequence (QRYLVFL in huCCRL2 and QRYRVSF in mCCRL2 instead of the conserved DRYLAIV motif) in the second intracellular loop which is essential for signal transduction [24].”
BackgroundInfluentialChen, Y., Liu, Z., Gong, P., Zhang, H., Chen, Y., Yao, S., Li, W., Zhang, Y., & Yu, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169041 · Cited by 25
“However, only CMKLR1 has been reported to be responsible for the inflammation and chemotaxis of immune cells induced by chemerin [16,19].”
Background
Metadata
- Authors
- Zabel, B. A., Nakae, S., Zúñiga, L., Kim, J.-Y., Ohyama, T., Alt, C., Pan, J., Suto, H., Soler, D., Allen, S. J., Handel, T. M., Song, C. H., Galli, S. J., & Butcher, E. C.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-09-15
- Volume
- 205
- Issue
- 10
- Pages
- 2207-2220
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2161903740
- Cited by
- 303
- References
- 45
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.